Pdl Biopharma, Inc.

Formerly NASDAQ: PDLI
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.A
from SC TO-I 22 pages PDL Biopharma, Inc. Fundamental Change Repurchase Right Notice, Notice of Right to Convert and Offer to Repurchase to Holders of 2.75% Convertible Senior Notes Due 2021
12/34/56
EX-1
from SC 13G 1 page Joint Filing Agreement
12/34/56
EX-1
from SC 13G/A 1 page Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 43 pages Pdl Biopharma, Inc. (A Delaware Corporation) $150,000,000 2.75% Convertible Senior Notes Due 2021 Underwriting Agreement Dated: November 16, 2016 Pdl Biopharma, Inc. (A Delaware Corporation) $150,000,000 2.75% Convertible Senior Notes Due 2021 Underwriting Agreement
12/34/56
EX-1.1
from 424B5 20 pages PDL Biopharma, Inc. $250,000,000 Debt Securities Common Stock Preferred Stock Depositary Shares Warrants Stock Purchase Contracts Stock Purchase Units Units of These Securities
12/34/56
EX-1
from 8-K 2 pages PDL Biopharma Commits to Equity Investment in Noden Pharma for the Acquisition of Tekturna® (Aliskiren) and Tekturna Hct® (Aliskiren and Hydrochlorothiazide) --Transaction Represents First Specialty Pharmaceutical Transaction by Pdl-- --Upon Close, Transaction Expected to Be Immediately Accretive
12/34/56
EX-1.1
from 8-K 55 pages Pdl Biopharma, Inc. (A Delaware Corporation) $260,870,000 4.00% Convertible Senior Notes Due 2018 Underwriting Agreement Dated: February 6, 2014 Pdl Biopharma, Inc. (A Delaware Corporation) $260,870,000 4.00% Convertible Senior Notes Due 2018 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 43 pages PDL Biopharma, Inc. (A Delaware Corporation) $135,000,000 3.75% Convertible Senior Notes Due 2015 Underwriting Agreement Dated: May 10, 2011 PDL Biopharma, Inc. (A Delaware Corporation) $135,000,000 3.75% Convertible Senior Notes Due 2015 Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1
from SC 13G/A 1 page Joint Acquisition Statement
12/34/56
EX-1
from SC 13G/A 1 page Joint Acquisition Statement
12/34/56
EX-1
from SC 13G 1 page Joint Aquisition Statement
12/34/56
EX-1.1
from S-3 ~20 pages Underwriting agreement
12/34/56
EX-1.1
from S-3/A ~20 pages Form of Underwriting Agreement
12/34/56